Cognoa: Funding, Investors & Team (Oct 2026)
A pediatric behavioral health business called Cognoa is creating digital diagnostics and therapies to help with the earlier detection and treatment of mental health issues like autism. Our goal is to better the long-term results for families and kids who are at risk of developmental delays. Our flagship products, the first prescription digital treatment for autistic children and the first digital diagnosis tool for autism, have both been given the FDA's Breakthrough Device designation. Cognoa's product pipeline will be able to address more unmet needs, including ADHD and anxiety, thanks to the company's AI technology platform. Cognoa intends to market Canvas DxTM as its tool for diagnosing autism. Visit CanvasDx.com for more details and to sign up for availability updates on Canvas DxTM.
Cognoa has raised $73.1M across 1 funding round on record, the most recent a Series B of $73.1M announced in Nov 2022.
That round is above the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Cognoa Company Profile and Key Stats
Latest funding round on record: Nov 2022.
Cognoa Funding Rounds
Cognoa Founders and Leadership Team
Contact details for the Cognoa team: 1 of 1 has an email address on file.
Start 14-day free trial →Cognoa Funding Compared to Other Biotechnology Startups
Cognoa's latest round of $73.1M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Cognoa in Biotechnology and Palo Alto
Companies Similar to Cognoa
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Cognoa Funding FAQs
What does Cognoa do?
A pediatric behavioral health business called Cognoa is creating digital diagnostics and therapies to help with the earlier detection and treatment of mental health issues like autism. Our goal is to better the long-term results for families and kids who are at risk of developmental delays. Our flagship products, the first prescription digital treatment for autistic children and the first digital diagnosis tool for autism, have both been given the FDA's Breakthrough Device designation. Cognoa's product pipeline will be able to address more unmet needs, including ADHD and anxiety, thanks to the company's AI technology platform. Cognoa intends to market Canvas DxTM as its tool for diagnosing autism. Visit CanvasDx.com for more details and to sign up for availability updates on Canvas DxTM.
How much funding has Cognoa raised?
Cognoa has raised $73.1M across 1 round on record. The most recent is a Series B of $73.1M announced in Nov 2022.
When did Cognoa last raise funding?
Cognoa's most recent funding round on record is a Series B of $73.1M, announced in Nov 2022.
Who founded Cognoa?
FundedIQ lists Dennis Wall (Founder) at Cognoa.
Where is Cognoa headquartered?
Cognoa is based in Palo Alto, California, United States.
How many employees does Cognoa have?
Cognoa is in the 51-100 employee band.
How does Cognoa's funding compare to other Biotechnology startups?
Cognoa's latest round of $73.1M is above the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Cognoa Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Cognoa is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.